XML 26 R17.htm IDEA: XBRL DOCUMENT
v3.21.2

STOCKHOLDERS EQUITY (Tables) | 9 Months Ended
--- | ---
Jun. 30, 2021
Warrants recorded as equity exercised |
|  | Three Months |  |  | Nine Months |
Warrants |  | Warrants Exercised |  |  | Exercise Price |  |  | Proceeds |  |  | Warrants Exercised |  |  | Exercise Price |  |  | Proceeds |
Series Z |  |  | - |  |  |  | - |  |  | $ | - |  |  |  | 79,200 |  |  | $ | 13.75 |  |  | $ | 1,089,000 |
Series ZZ |  |  | 19,200 |  |  | $ | 13.75 |  |  |  | 264,000 |  |  |  | 20,000 |  |  | $ | 13.75 |  |  |  | 275,000 |
Series AA |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 100,000 |  |  | $ | 13.75 |  |  |  | 1,375,000 |
Series CC |  |  | 5,000 |  |  | $ | 5.00 |  |  |  | 25,000 |  |  |  | 107,298 |  |  | $ | 5.00 |  |  |  | 536,490 |
|  |  | 24,200 |  |  |  |  |  |  | $ | 289,000 |  |  |  | 306,498 |  |  |  |  |  |  | $ | 3,275,490 |
|  | Three Months |  |  | Nine Months |
Warrants |  | Warrants Exercised |  |  | Exercise Price |  |  | Proceeds |  |  | Warrants Exercised |  |  | Exercise Price |  |  | Proceeds |
Series V |  |  | 674,164 |  |  | $ | 13.75 |  |  | $ | 9,269,755 |  |  |  | 674,164 |  |  | $ | 13.75 |  |  | $ | 9,269,755 |
Series CC |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 123,820 |  |  | $ | 5.00 |  |  |  | 619,100 |
Series FF |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 68,048 |  |  | $ | 3.91 |  |  |  | 265,812 |
Series HH |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 6,300 |  |  | $ | 3.13 |  |  |  | 19,687 |
Series JJ |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 9,450 |  |  | $ | 3.13 |  |  |  | 29,531 |
Series LL |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 26,398 |  |  | $ | 3.59 |  |  |  | 94,867 |
|  |  | 674,164 |  |  |  |  |  |  | $ | 9,269,755 |  |  |  | 908,180 |  |  |  |  |  |  | $ | 10,298,752 |
Stock options, stock bonuses and compensation granted by the Company |
Name of Plan |  | Total Shares Reserved Under Plans |  |  | Shares Reserved for Outstanding Options |  |  | Shares Issued |  |  | Remaining Options/Shares Under Plans |
Incentive Stock Options Plans |  |  | 138,400 |  |  |  | 76,829 |  |  |  | N/A |  |  |  | 213 |
Non-Qualified Stock Option Plans |  |  | 11,787,200 |  |  |  | 11,001,880 |  |  |  | N/A |  |  |  | 404,826 |
Stock Bonus Plans |  |  | 783,760 |  |  |  | N/A |  |  |  | 358,118 |  |  |  | 425,609 |
Stock Compensation Plans |  |  | 634,000 |  |  |  | N/A |  |  |  | 150,695 |  |  |  | 464,895 |
Incentive Stock Bonus Plan |  |  | 640,000 |  |  |  | N/A |  |  |  | 614,500 |  |  |  | 25,500 |
Stock option activity |
|  | Nine Months Ended June 30, |
|  | 2021 |  |  | 2020 |
Options granted |  |  | 2,603,500 |  |  |  | 2,561,200 |
Options exercised |  |  | 126,954 |  |  |  | 94,199 |
Options forfeited |  |  | 42,166 |  |  |  | 1,000 |
Options expired |  |  | 9,374 |  |  |  | 1,180 |
|  | Three Months Ended June 30, |
|  | 2021 |  |  | 2020 |
Options granted |  |  | 2,595,500 |  |  |  | 2,559,000 |
Options exercised |  |  | 72,809 |  |  |  | 73,719 |
Options forfeited |  |  | - |  |  |  | 16 |
Options expired |  |  | 9,307 |  |  |  | - |
Stock-based compensation expense |
|  | Nine months Ended June 30, |
|  | 2021 |  |  | 2020 |
Employees |  | $ | 10,090,410 |  |  | $ | 6,690,331 |
Non-employees |  | $ | 955,900 |  |  | $ | 623,146 |
|  | Three months Ended June 30, |
|  | 2021 |  |  | 2020 |
Employees |  | $ | 3,511,359 |  |  | $ | 3,109,127 |
Non-employees |  | $ | 403,236 |  |  | $ | 275,919 |
Derivative liabilities, warrants and other options |
Warrant/Options |  | Issue Date |  | Shares Issuable upon Exercise of Warrants/ Options |  |  | Exercise Price |  |  | Expiration Date |  |  | Reference |
Series N |  | 8/18/2008 |  |  | 85,339 |  |  | $ | 3.00 |  |  | 8/18/2022 |  |  | 2 |
Series UU |  | 6/11/2018 |  |  | 93,603 |  |  | $ | 2.80 |  |  | 6/30/2022 |  |  | 2 |
Series X |  | 1/13/2016 |  |  | 120,000 |  |  | $ | 9.25 |  |  | 7/13/2022 |  |  | 2 |
Series Y |  | 2/15/2016 |  |  | 26,000 |  |  | $ | 12.00 |  |  | 8/15/2022 |  |  | 2 |
Series BB |  | 8/26/2016 |  |  | 16,000 |  |  | $ | 13.75 |  |  | 8/22/2021 |  |  | * |
Series Z |  | 5/23/2016 |  |  | 184,800 |  |  | $ | 13.75 |  |  | 11/23/2021 |  |  | * |
Series CC |  | 12/8/2016 |  |  | 41,345 |  |  | $ | 5.00 |  |  | 12/8/2021 |  |  | 1 |
Series HH |  | 2/23/2017 |  |  | 200 |  |  | $ | 3.13 |  |  | 2/16/2022 |  |  | * |
Series AA |  | 8/26/2016 |  |  | 100,000 |  |  | $ | 13.75 |  |  | 2/22/2022 |  |  | * |
Series MM |  | 6/22/2017 |  |  | 333,432 |  |  | $ | 1.86 |  |  | 6/22/2022 |  |  | 2 |
Series NN |  | 7/24/2017 |  |  | 217,838 |  |  | $ | 2.52 |  |  | 7/24/2022 |  |  | 2 |
Series RR |  | 10/30/2017 |  |  | 251,761 |  |  | $ | 1.65 |  |  | 10/30/2022 |  |  | 2 |
Series SS |  | 12/19/2017 |  |  | 220,800 |  |  | $ | 2.09 |  |  | 12/18/2022 |  |  | * |
Series TT |  | 2/5/2018 |  |  | 100,868 |  |  | $ | 2.24 |  |  | 2/5/2023 |  |  | 2 |
Consultants |  | 7/28/2017 – 11/18/2020 |  |  | 15,000 |  |  | $ | 2.18 - $11.61 |  |  | 11/17/2022 - 7/27/2027 |  |  | 3 |
Schedule of fair value of warrant liabilites |
|  | June 30, 2021 |  |  | September 30, 2020 |
Series W warrants |  | $ | - |  |  | $ | 73,570 |
Series Z warrants |  |  | 429,996 |  |  |  | 1,207,902 |
Series ZZ warrants |  |  | - |  |  |  | 75,044 |
Series AA warrants |  |  | 263,818 |  |  |  | 1,082,212 |
Series BB warrants |  |  | 16,696 |  |  |  | 65,173 |
Series CC warrants |  |  | 206,978 |  |  |  | 1,259,712 |
Series HH warrants |  |  | 1,216 |  |  |  | 2,000 |
Total warrant liabilities |  | $ | 918,704 |  |  | $ | 3,765,613 |
Schedule of gain and (losses) on derivative liabilities |
|  | 2021 |  |  | 2020 |
Series V warrants |  | $ | - |  |  | $ | 185,652 |
Series W warrants |  |  | 73,570 |  |  |  | (614,696 | )
Series Z warrants |  |  | (113,094 | ) |  |  | (742,495 | )
Series ZZ warrants |  |  | (98,692 | ) |  |  | (38,319 | )
Series AA warrants |  |  | (306,606 | ) |  |  | (547,454 | )
Series BB warrants |  |  | 48,477 |  |  |  | (44,620 | )
Series CC warrants |  |  | (596,001 | ) |  |  | (1,245,627 | )
Series FF warrants |  |  | - |  |  |  | (319,706 | )
Series HH warrants |  |  | 784 |  |  |  | (35,024 | )
Series JJ warrants |  |  | - |  |  |  | (64,992 | )
Series LL warrants |  |  | - |  |  |  | (98,066 | )
Net loss on warrant liabilities |  | $ | (991,562 | ) |  | $ | (3,565,347 | )
|  | 2021 |  |  | 2020 |
Series V warrants |  | $ | - |  |  | $ | 107,191 |
Series W warrants |  |  | - |  |  |  | (247,327 | )
Series Z warrants |  |  | 583,404 |  |  |  | (430,619 | )
Series ZZ warrants |  |  | (87,162 | ) |  |  | (33,734 | )
Series AA warrants |  |  | 355,215 |  |  |  | (220,831 | )
Series BB warrants |  |  | 64,678 |  |  |  | (37,592 | )
Series CC warrants |  |  | 199,256 |  |  |  | (419,350 | )
Series HH warrants |  |  | 1,228 |  |  |  | (567 | )
Net (gain) loss on warrant liabilities |  | $ | 1,116,619 |  |  | $ | (1,282,829 | )
|  | Nine Months Ended |  |  | Three Months Ended |
|  | June 30, 2021 |  |  | June 30, 2020 |  |  | June 30, 2021 |  |  | June 30, 2020 |
Realized through the resale of shares |  | $ | 1,436,473 |  |  | $ | 2,539,245 |  |  | $ | 761,237 |  |  | $ | 818,565 |
Fair value of shares upon issuance |  |  | - |  |  |  | 1,769,500 |  |  |  | - |  |  |  | 1,769,500 |
Other non-operating gain (loss) |  | $ | 1,436,473 |  |  | $ | 769,745 |  |  | $ | 761,237 |  |  | $ | (950,935 | )
Options and Warrants [Member] |
Warrants recorded as equity exercised |
|  | Three Months |  |  | Nine Months |
Warrants |  | Warrants Exercised |  |  | Exercise Price |  |  | Proceeds |  |  | Warrants Exercised |  |  | Exercise Price |  |  | Proceeds |
Series MM |  |  | 147,929 |  |  | $ | 1.86 |  |  | $ | 275,148 |  |  |  | 464,201 |  |  | $ | 1.86 |  |  | $ | 863,414 |
Series NN |  |  | 109,170 |  |  | $ | 2.52 |  |  |  | 275,108 |  |  |  | 131,004 |  |  | $ | 2.52 |  |  |  | 330,130 |
Series RR |  |  | 95,799 |  |  | $ | 1.65 |  |  |  | 158,068 |  |  |  | 165,888 |  |  | $ | 1.65 |  |  |  | 273,715 |
Series SS |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 105,264 |  |  | $ | 2.09 |  |  |  | 220,002 |
Series TT |  |  | 60,214 |  |  | $ | 2.24 |  |  |  | 134,879 |  |  |  | 270,696 |  |  | $ | 2.24 |  |  |  | 606,359 |
|  |  | 413,112 |  |  |  |  |  |  | $ | 843,204 |  |  |  | 1,137,053 |  |  |  |  |  |  | $ | 2,293,620 |
|  | Three Months |  |  | Nine Months |
Warrants |  | Warrants Exercised |  |  | Exercise Price |  |  | Proceeds |  |  | Warrants Exercised |  |  | Exercise Price |  |  | Proceeds |
Series NN |  |  | - |  |  |  | - |  |  | $ | - |  |  |  | 98,253 |  |  | $ | 2.52 |  |  | $ | 247,598 |
Series OO |  |  | 10,000 |  |  | $ | 2.52 |  |  |  | 25,200 |  |  |  | 50,000 |  |  | $ | 2.52 |  |  |  | 126,000 |
Series SS |  |  | 39,474 |  |  | $ | 2.09 |  |  |  | 82,500 |  |  |  | 156,580 |  |  | $ | 2.09 |  |  |  | 327,252 |
Series TT |  |  | 10,000 |  |  | $ | 2.24 |  |  |  | 22,400 |  |  |  | 188,125 |  |  | $ | 2.24 |  |  |  | 421,400 |
Series UU |  |  | 61,207 |  |  | $ | 2.80 |  |  |  | 171,380 |  |  |  | 61,207 |  |  | $ | 2.80 |  |  |  | 171,380 |
Series VV |  |  | 55,000 |  |  | $ | 1.75 |  |  |  | 96,250 |  |  |  | 82,500 |  |  | $ | 1.75 |  |  |  | 144,375 |
|  |  | 175,681 |  |  |  |  |  |  | $ | 397,730 |  |  |  | 636,665 |  |  |  |  |  |  | $ | 1,438,005 |

X
- References No definition available. + Details
Name: | cvm_ExercisedWarrantsRecordedAsEquityTableTextBlock
Namespace Prefix: | cvm_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | cvm_ScheduleOfDerivativeLiabilitiesWarrantsAndOtherOptions
Namespace Prefix: | cvm_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | cvm_ScheduleOfFairValueOfWarrantLiabilitestabletextblock
Namespace Prefix: | cvm_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | cvm_ScheduleOfGainAndLossesOnDerivativeLiabilitiesTableTextBlock
Namespace Prefix: | cvm_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | cvm_ScheduleStockOptionsStockBonusesAndCompensationGrantedByCompany
Namespace Prefix: | cvm_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an equity-based arrangement (such as stock or unit options and stock or unit awards) with an individual employee, which is generally an employment contract between the entity and a selected officer or key employee containing a promise by the employer to pay certain equity-based awards at future dates, sometimes including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period, the number of shares or units issued during the period under such arrangements, and the carrying amount as of the balance sheet date of the related liability. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 710 -SubTopic 10 -Section 30 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6409875&loc=d3e20015-108363 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 710 -SubTopic 10 -Section 55 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=6409961&loc=d3e20517-108367 + Details
Name: | us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_OptionIndexedToIssuersEquityEquityAxis=cvm_OptionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |